Results 201 to 210 of about 19,533 (266)
Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer. [PDF]
OncogeneBrooke GN +14 more
europepmc +1 more source
Obesity Reviews, EarlyView.ABSTRACT Objective This systematic review and meta‐analysis aimed to identify common life‐course body mass index (BMI) trajectories (childhood/adulthood to adulthood) and their impact on risk of cancer overall and cancer at different sites in adulthood. Methods Observational studies were identified that assessed the association of BMI trajectories with
Samira Behboudi‐Gandevani +6 more
wiley +1 more source
Emerging Medical Therapies for Primary Aldosteronism. [PDF]
HypertensionVibhatavata P, Turcu AF.
europepmc +1 more source
Endocrine Disruptors and Breast Cancer: A Comprehensive Review. [PDF]
BiomedicinesCzaczkowska L +2 more
europepmc +1 more source
Effects of GLP‐1 Receptor Agonists on Hair Loss and Regrowth: A Systematic Review
International Journal of Dermatology, EarlyView.
Miranda K. Branyiczky +4 more
wiley +1 more source
The proteostasis paradox: from systemic collapse in aging to pathway-specific addiction in prostate cancer. [PDF]
Front Cell Dev BiolGuo D, Peng Y, Yu Y.
europepmc +1 more source
Real-World Treatment Patterns in Patients with Metastatic Castration-Sensitive Prostate Cancer in Japan: A Retrospective Health Administrative Data Analysis. [PDF]
Adv TherKawai T +4 more
europepmc +1 more source
Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment. [PDF]
J Bras NefrolMathew GG.
europepmc +1 more source